Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07214545 · ClinicalTrials.gov registry record · NA

External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms

A NA study of Autism Spectrum Disorder (ASD) and Attention Deficit Disorder With Hyperactivity (ADHD), sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07214545 is a NA study of Autism Spectrum Disorder (ASD) and Attention Deficit Disorder With Hyperactivity (ADHD) that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 60 participants, below the 99-participant average among 16 other Autism Spectrum Disorder (ASD) trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07214545, a NA study of Autism Spectrum Disorder (ASD) and Attention Deficit Disorder With Hyperactivity (ADHD), is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: * Does eTNS reduce ADHD symptoms? * Does eTNS improve core and associated features of ASD? Participation spans 8-12 weeks and includes: * 4-5 in-person visits * 4 brief virtual check-ins * Nightly use of the eTNS device with a small sticky patch applied to child's forehead * Randomized assignment (those who start with the sham device may try the active device later)

Conditions Studied

Autism Spectrum Disorder (ASD) Attention Deficit Disorder With Hyperactivity (ADHD)

Interventions

  • DEVICE Trigeminal Nerve Stimulation
  • DEVICE Sham Trigeminal Nerve Stimulation

Study Locations (1)

California

  • UCSF Nancy Friend Pritzker Psychiatry Building - San Francisco

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-10-06
Est. Completion 2028-01-31
Phase NA

Sponsor

University of California, San Francisco

1,713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07214545

The ClinicalTrials.gov registry entry for NCT07214545 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99-participant average among 16 other Autism Spectrum Disorder (ASD) trials with a reported enrollment target (39% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder (ASD) appearing as the primary indexed condition, and to 2 interventions - of which Trigeminal Nerve Stimulation is the first listed.

NCT07214545 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07214545 about?

NCT07214545 is a clinical study titled "External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms". The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: * Does eTNS reduce ...

What is the current status of trial NCT07214545?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-10-06. Estimated completion is 2028-01-31.

What conditions does trial NCT07214545 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder (ASD), Attention Deficit Disorder With Hyperactivity (ADHD).

What interventions are being tested in trial NCT07214545?

The interventions under investigation include: Trigeminal Nerve Stimulation (DEVICE), Sham Trigeminal Nerve Stimulation (DEVICE).

Who is sponsoring clinical trial NCT07214545?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07214545 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism Spectrum Disorder (ASD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism Spectrum Disorder (ASD)

All registered trials for this condition

Attention Deficit Disorder With Hyperactivity (ADHD)

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.